240 related articles for article (PubMed ID: 17309878)
1. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
[TBL] [Abstract][Full Text] [Related]
2. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
3. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
4. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
6. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
8. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
9. Study of tauopathies by comparing Drosophila and human tau in Drosophila.
Chen X; Li Y; Huang J; Cao D; Yang G; Liu W; Lu H; Guo A
Cell Tissue Res; 2007 Jul; 329(1):169-78. PubMed ID: 17406902
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions.
Chee FC; Mudher A; Cuttle MF; Newman TA; MacKay D; Lovestone S; Shepherd D
Neurobiol Dis; 2005 Dec; 20(3):918-28. PubMed ID: 16023860
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions.
Chee F; Mudher A; Newman TA; Cuttle M; Lovestone S; Shepherd D
Biochem Soc Trans; 2006 Feb; 34(Pt 1):88-90. PubMed ID: 16417489
[TBL] [Abstract][Full Text] [Related]
12. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
[TBL] [Abstract][Full Text] [Related]
13. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans.
Kraemer BC; Burgess JK; Chen JH; Thomas JH; Schellenberg GD
Hum Mol Genet; 2006 May; 15(9):1483-96. PubMed ID: 16600994
[TBL] [Abstract][Full Text] [Related]
15. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
[TBL] [Abstract][Full Text] [Related]
16. Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity.
Butzlaff M; Hannan SB; Karsten P; Lenz S; Ng J; Voßfeldt H; Prüßing K; Pflanz R; Schulz JB; Rasse T; Voigt A
Hum Mol Genet; 2015 Jul; 24(13):3623-37. PubMed ID: 25794683
[TBL] [Abstract][Full Text] [Related]
17. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations
Bardai FH; Wang L; Mutreja Y; Yenjerla M; Gamblin TC; Feany MB
J Neurosci; 2018 Jan; 38(1):108-119. PubMed ID: 29138281
[TBL] [Abstract][Full Text] [Related]
18. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
19. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
20. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
